183 related articles for article (PubMed ID: 27163850)
1. In vitro evaluation of the catalytic activity of paraoxonases and phosphotriesterases predicts the enzyme circulatory levels required for in vivo protection against organophosphate intoxications.
Ashani Y; Leader H; Aggarwal N; Silman I; Worek F; Sussman JL; Goldsmith M
Chem Biol Interact; 2016 Nov; 259(Pt B):252-256. PubMed ID: 27163850
[TBL] [Abstract][Full Text] [Related]
2. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
[TBL] [Abstract][Full Text] [Related]
3. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
[TBL] [Abstract][Full Text] [Related]
4. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
[TBL] [Abstract][Full Text] [Related]
6. Single treatment of VX poisoned guinea pigs with the phosphotriesterase mutant C23AL: Intraosseous versus intravenous injection.
Wille T; Neumaier K; Koller M; Ehinger C; Aggarwal N; Ashani Y; Goldsmith M; Sussman JL; Tawfik DS; Thiermann H; Worek F
Toxicol Lett; 2016 Sep; 258():198-206. PubMed ID: 27397758
[TBL] [Abstract][Full Text] [Related]
7. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro.
Goldsmith M; Eckstein S; Ashani Y; Greisen P; Leader H; Sussman JL; Aggarwal N; Ovchinnikov S; Tawfik DS; Baker D; Thiermann H; Worek F
Arch Toxicol; 2016 Nov; 90(11):2711-2724. PubMed ID: 26612364
[TBL] [Abstract][Full Text] [Related]
8. Post-VX exposure treatment of rats with engineered phosphotriesterases.
Stigler L; Köhler A; Koller M; Job L; Escher B; Potschka H; Thiermann H; Skerra A; Worek F; Wille T
Arch Toxicol; 2022 Feb; 96(2):571-583. PubMed ID: 34962578
[TBL] [Abstract][Full Text] [Related]
9. Progress in the development of enzyme-based nerve agent bioscavengers.
Nachon F; Brazzolotto X; Trovaslet M; Masson P
Chem Biol Interact; 2013 Dec; 206(3):536-44. PubMed ID: 23811386
[TBL] [Abstract][Full Text] [Related]
10. Steady-State Kinetics of Enzyme-Catalyzed Hydrolysis of Echothiophate, a P-S Bonded Organophosphorus as Monitored by Spectrofluorimetry.
Zueva IV; Lushchekina SV; Daudé D; Chabrière E; Masson P
Molecules; 2020 Mar; 25(6):. PubMed ID: 32192230
[TBL] [Abstract][Full Text] [Related]
11. Catalytic bioscavengers as countermeasures against organophosphate nerve agents.
Goldsmith M; Ashani Y
Chem Biol Interact; 2018 Aug; 292():50-64. PubMed ID: 29990481
[TBL] [Abstract][Full Text] [Related]
12. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate.
Sunay SZ; Kayaaltı Z; Bayrak T; Söylemezoğlu T
Toxicol Ind Health; 2015 Dec; 31(12):1061-8. PubMed ID: 23625910
[TBL] [Abstract][Full Text] [Related]
13. Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning.
Bajaj P; Tripathy RK; Aggarwal G; Datusalia AK; Sharma SS; Pande AH
Appl Biochem Biotechnol; 2016 Sep; 180(1):165-76. PubMed ID: 27131877
[TBL] [Abstract][Full Text] [Related]
14. Investigation of evolved paraoxonase-1 variants for prevention of organophosphorous pesticide compound intoxication.
Mata DG; Rezk PE; Sabnekar P; Cerasoli DM; Chilukuri N
J Pharmacol Exp Ther; 2014 Jun; 349(3):549-58. PubMed ID: 24706983
[TBL] [Abstract][Full Text] [Related]
15. Assessing protection against OP pesticides and nerve agents provided by wild-type HuPON1 purified from Trichoplusia ni larvae or induced via adenoviral infection.
Hodgins SM; Kasten SA; Harrison J; Otto TC; Oliver ZP; Rezk P; Reeves TE; Chilukuri N; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):177-80. PubMed ID: 23123254
[TBL] [Abstract][Full Text] [Related]
16. Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity.
Valiyaveettil M; Alamneh YA; Doctor BP; Nambiar MP
Toxicol Lett; 2012 Apr; 210(1):87-94. PubMed ID: 22301377
[TBL] [Abstract][Full Text] [Related]
17. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
18. Engineered Recombinant PON1-OPH Fusion Hybrids: Potentially Effective Catalytic Bioscavengers against Organophosphorus Nerve Agent Analogs.
Lee N; Yun H; Lee C; Lee Y; Kim E; Kim S; Jeon H; Yu C; Rho J
J Microbiol Biotechnol; 2021 Jan; 31(1):144-153. PubMed ID: 33144547
[TBL] [Abstract][Full Text] [Related]
19. In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates.
Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Farag HA; Agrawal P; Doctor BP; Nambiar MP
Toxicol In Vitro; 2011 Jun; 25(4):905-13. PubMed ID: 21382471
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs.
Valiyaveettil M; Alamneh Y; Rezk P; Biggemann L; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
Biochem Pharmacol; 2011 Mar; 81(6):800-9. PubMed ID: 21219877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
